drugset / Trial / NCT05583357
Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351
RandomizedCrossoverOpen-labelPrevention
Summary
It is a single center, randomized, open-labeled, blind endpoint evaluation, exploratory clinical study to evaluate the safety and immunogenicity of bivalent vaccine V-01D-351 as a booster.
Timeline
- Start
- 2022-08-15
- Primary completion
- 2022-09-13
- Completion
- 2023-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CoronaVac | Vaccine | — | — |
| Subject | V-01D-351 | Vaccine | — | — |